Browse the evidence

Replacing saturated fatty acids with omega-6 polyunsaturated fatty acids has a neutral effect on blood pressure.

Switching from saturated fats to omega-6 oils will not significantly lower your blood pressure. If blood pressure management is your primary goal, other dietary strategies (like reducing sodium or increasing potassium) may be more effective, though this substitution still benefits cholesterol levels.

A 2-year low-carbohydrate high-protein (LCHP) diet does not cause harmful effects on glomerular filtration rate (GFR), albuminuria, or electrolyte balance in healthy obese individuals compared to a low-fat diet, despite inducing glomerular hyperfiltration.

If you are obese but have healthy kidneys (no diabetes or high blood pressure), you can follow a low-carb, high-protein diet for weight loss without fearing kidney damage. While your kidneys will filter more blood (hyperfiltration) and you may urinate more, this is a normal physiological response to high protein and does not lead to kidney disease in healthy people over a 2-year period.

In older men, the spatial distance between type II muscle fiber-associated satellite cells (SC) and capillaries is significantly greater than in young men, which may impair SC activation and contribute to age-related muscle atrophy.

As men age, the communication line between muscle stem cells (satellite cells) and blood vessels (capillaries) weakens, specifically in fast-twitch muscle fibers. This physical distance may make it harder for muscles to repair and grow after exercise. To counteract this, older adults should prioritize resistance training, which has been shown to activate satellite cells and potentially improve their proximity to capillaries, supporting muscle maintenance.

Following a single bout of resistance exercise, activated satellite cells (MyoD+) are located significantly closer to capillaries than quiescent satellite cells (MyoD-) in young men, suggesting that proximity to capillaries facilitates SC activation.

Resistance exercise triggers satellite cells to activate, and these activated cells tend to be closer to blood vessels, which likely helps deliver the nutrients and signals they need to repair muscle. This highlights the importance of resistance training for maintaining muscle health, especially as we age.

A low-fat diet intervention (targeting 20% of calories from fat) does not reduce the incidence of coronary heart disease, stroke, or type 2 diabetes compared to a control group with minimal dietary guidance.

Do not rely on a low-fat diet as a primary strategy for preventing heart disease or diabetes. Simply reducing fat to 20% without improving the quality of the remaining calories (e.g., replacing with refined carbs) does not improve outcomes.

Premenopausal women exhibit sex-specific fat distribution characterized by preferential subcutaneous adipose tissue (SAT) storage and higher brown adipose tissue (BAT) activity, which provides metabolic protection against visceral obesity and cardiovascular disease compared to men.

If you are a premenopausal woman, your body naturally stores fat in your hips and thighs (subcutaneous) rather than around your organs (visceral), and you likely have more active brown fat for energy burning. This is a biological advantage for metabolic health. Do not equate higher total body fat with higher health risk compared to men; your distribution pattern is protective.

Supplementing with whey protein, soy protein, or isolated leucine (standardized to ~3g leucine per serving) provides no additional benefit for increasing skeletal muscle mass or strength compared to a placebo when combined with resistance training in previously untrained college-aged males who already consume adequate protein (>1.3 g/kg/day) and increase caloric intake.

If you are a beginner lifter eating enough protein (over 1.3g/kg/day) and eating enough calories to support training, you do not need to spend extra money on whey, soy, or leucine supplements. They will not help you build more muscle or strength compared to a placebo, as long as your total diet is sufficient. Focus on your training and total food intake first.

Eight weeks of fish oil supplementation (5 g/day) suppresses anabolic signaling (panPKB, p70S6K1, AMPKa2) in response to resistance exercise and protein ingestion without increasing myofibrillar muscle protein synthesis rates in young, resistance-trained men.

If you are a young, resistance-trained man, taking 5g of fish oil daily for 8 weeks will not increase your muscle protein synthesis rates after working out and eating protein. It actually suppresses key anabolic signaling markers (like p70S6K1) without providing any anabolic benefit. Do not rely on fish oil to boost muscle growth; it may be neutral or even counterproductive to signaling in this specific demographic.

High baseline plasma levels of specific advanced glycation end products (G-H1) and oxidation products (2-AAA) are strongly associated with greater severity of subclinical atherosclerosis (measured by CIMT, CAC, and AAC) over a 10-year follow-up in patients with type 2 diabetes.

For people with type 2 diabetes, maintaining good blood sugar control early and consistently is crucial because high blood sugar creates lasting chemical byproducts (AGEs and OxPs) that damage blood vessels for years, even after glucose levels are normalized. This damage contributes to heart disease risk long-term, highlighting the importance of early intervention and sustained management rather than just recent control.

Coronary Microvascular Dysfunction (CMD) is a significant predictor of adverse cardiovascular events, heart failure with preserved ejection fraction (HFpEF), and mortality in diabetic patients, even in the absence of obstructive coronary artery disease.

Normal results on a standard angiogram (looking for big blockages) do not guarantee heart health if you have diabetes. Microvascular dysfunction can still cause heart failure and heart attacks. Monitoring for symptoms like shortness of breath and chest pain is crucial, as these may signal microvascular issues.

Long-term elevated plasma TMAO levels are associated with a higher risk of incident atherosclerotic cardiovascular disease (ASCVD), but this association is significantly modified by renal function, being present only in individuals with impaired renal function (eGFR <60 mL/min/1.73 m2).

If you have impaired kidney function (eGFR <60), high TMAO levels are a significant warning sign for heart disease risk. If your kidney function is normal, high TMAO levels may not carry the same risk. Focus on maintaining kidney health and discussing TMAO testing with your doctor if you have known renal impairment.

Elevated plasma TMAO levels are associated with a higher risk of recurrent ASCVD in individuals with preexisting cardiovascular disease, independent of renal function status.

If you have a history of heart disease, higher TMAO levels are linked to a higher risk of another heart event. This risk exists regardless of your kidney function. Discussing TMAO levels with your cardiologist may help tailor your prevention strategy.

Replacing sugar-sweetened beverages (SSBs) with unsweetened beverages (USBs) or artificially sweetened beverages (ASBs) for 12 months does not significantly improve cardiometabolic risk factors (specifically the TG:HDL-C ratio) in the general adult population.

If you drink sugary beverages daily, switching to water or diet soda for a year won't necessarily fix your cholesterol or triglyceride ratios on its own. However, if you carry excess weight around your midsection, switching to either water or diet soda can help you lose weight compared to continuing sugary drinks. Water is better if you want to reduce your craving for sweet tastes.

Higher circulating levels of long-chain omega-3 polyunsaturated fatty acids (specifically DHA) are associated with a lower prevalence of subclinical brain infarcts and better white matter integrity in older adults.

For older adults, maintaining higher levels of long-chain omega-3s (found in fatty fish) is linked to fewer silent brain strokes and better white matter health. This suggests that prioritizing fish consumption may help protect against cognitive decline and dementia risk factors later in life.

Higher circulating levels of long-chain omega-3 PUFAs are associated with a lower risk of worsening white matter grade over a 5-year period in older adults.

Consistent intake of long-chain omega-3s may help slow the progression of white matter changes in the brain, which are linked to cognitive decline. This benefit was observed in a 5-year follow-up, suggesting long-term consistency is key.

Counter-regulatory mechanisms, specifically adaptive thermogenesis and increased eating drive, are potent physiological responses to weight loss that actively promote weight regain, thereby limiting the long-term efficacy of lifestyle interventions and pharmacotherapies.

When you lose weight, your body fights back by lowering your metabolic rate and increasing hunger. This is a normal biological response, not a personal failure. To maintain weight loss, you must anticipate this metabolic adaptation and likely require ongoing, structured support rather than relying on initial willpower alone.

Bariatric surgery achieves superior long-term weight loss compared to lifestyle interventions, but this comes with complex physiological changes including transient decreases in resting metabolic rate per fat-free mass and alterations in gut peptides like GLP-1 and PYY.

Bariatric surgery is currently the most effective long-term treatment for obesity, achieving ~25% weight loss. However, it works through complex hormonal changes (like increased GLP-1) and metabolic adaptations, not just stomach size reduction. It requires lifelong medical monitoring.

Skeletal muscle transcriptomic profiling, specifically focusing on a core set of 332 insulin-sensitive genes (CORE-IS) and non-coding RNAs, provides a robust molecular signature for metabolic disease that correlates with genetic loci identified by GWAS and responds to clinical interventions.

This research does not offer a direct lifestyle or supplement intervention. Instead, it highlights that current genetic testing (GWAS) is insufficient for predicting metabolic disease risk without functional data. It suggests that future diagnostics may rely on gene expression profiles (transcriptomics) from muscle tissue to accurately assess insulin sensitivity and metabolic health, potentially guiding personalized treatment strategies for type 2 diabetes and obesity.

Cardiovascular polypills (low-dose combinations of BP, lipid, and anti-thrombotic drugs) may serve as a partial exercise mimetic for cardiovascular risk reduction, though they do not fully replicate exercise's protective mechanisms.

If you cannot exercise, a cardiovascular polypill (combining low-dose BP, lipid, and anti-clotting meds) is a viable, evidence-based strategy to reduce cardiovascular risk. It is not a perfect substitute for exercise but offers significant protection with good adherence rates.

Higher circulating levels of very-long-chain saturated fatty acids (VLSFAs), specifically lignoceric acid (24:0), behenic acid (22:0), and arachidic acid (20:0), are associated with a lower risk of incident heart failure in older adults.

For older adults, maintaining higher levels of very-long-chain saturated fatty acids (like 24:0, 22:0, and 20:0) in the blood is linked to a lower risk of developing heart failure. These fatty acids come from both diet (e.g., peanuts, macadamia nuts, canola oil) and the body's own metabolism. While this doesn't mean you should aggressively supplement saturated fats, it suggests that a diet including these specific fatty acids may be protective. Focus on whole food sources like nuts and seeds rather than processed fats.

Higher baseline expression of caveolin-1 in adipocytes enables greater hypertrophic expansion (fat cell enlargement) in response to caloric overfeeding in healthy humans.

Your body's ability to store fat in your cells (hypertrophy) when you eat more is linked to the levels of a protein called caveolin-1. People with higher levels of this protein tend to get larger fat cells rather than creating new ones. While you cannot directly 'take' caveolin-1, understanding that fat cells are dynamic and responsive to lipid levels (shrinking when mobilized) suggests that metabolic flexibility is key.

GLP-1 receptor agonists are associated with a modestly increased risk of gallbladder and biliary disorders, particularly at higher doses and longer treatment durations.

Be aware that GLP-1 medications can slightly increase your risk of gallbladder issues, such as gallstones or inflammation. This risk is higher if you take higher doses or use the medication for a long time. While the absolute risk is low, report any severe abdominal pain to your doctor promptly.

Obesity alters the pharmacokinetics of drugs, affecting absorption, distribution, metabolism, and excretion, which may necessitate dose adjustments for certain medications.

If you have obesity, tell your doctor about all medications you take. Your body may process drugs differently, requiring dose adjustments for safety and effectiveness, especially for drugs metabolized by the liver or kidneys.

Obesity induces chronic low-grade inflammation (LGCI) via adipose tissue hypertrophy, immune cell infiltration (M1 macrophages), and cytokine release (TNF-α, IL-6, IL-1β), which disrupts insulin signaling through JNK and NF-κB pathways, leading to systemic insulin resistance and metabolic dysfunction.

If you have obesity, your body is likely in a state of chronic, low-grade inflammation that actively works against your metabolic health. This isn't just 'being fat'; it's a biological state that disrupts how your body handles insulin and energy. Addressing this inflammation through lifestyle changes (diet, exercise) or medical interventions is crucial for breaking the cycle of metabolic dysfunction.